Farther Finance Advisors, LLC

Position in DHR — Danaher Corp /De/

CIK 1992825 SAN FRANCISCO, CA

Position in DHR

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$3,523,147

+$257,146 QoQ

Shares Held

18,582

+30.2% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $17,580,572 across 34 Diagnostics & Research names. DHR ranks #2 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	9,904	$4,868,113
2	DHR	Danaher Corp /De/ This page	18,582	$3,523,147
3	IQV	Iqvia Holdings Inc.	12,310	$2,099,347
4	IDXX	Idexx Laboratories Inc /De	2,593	$1,456,980
5	MEDP	Medpace Holdings, Inc.	2,083	$1,000,235
6	LH	Labcorp Holdings Inc.	3,417	$911,689
7	WAT	Waters Corp /De/	1,973	$587,559
8	A	Agilent Technologies, Inc.	5,090	$580,158

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,523,147	18,582	+30.2%	Shares	Sole	2026-04-07
2025-12-31	$3,266,001	14,267	+24.6%	Shares	Sole	2026-01-23
2025-09-30	$2,270,870	11,454	-12.7%	Shares	Sole	2025-10-14
2025-06-30	$2,590,934	13,116	+50.4%	Shares	Sole	2025-07-11
2025-03-31	$1,787,395	8,719	+12.0%	Shares	Sole	2025-04-14
2024-12-31	$1,786,817	7,784	+13.8%	Shares	Sole	2025-02-10
2024-09-30	$1,901,934	6,841	-3.0%	Shares	Sole	2024-10-29
2024-06-30	$1,761,442	7,050	+60.5%	Shares	Sole	2024-07-31
2024-03-31	$1,096,770	4,392	+24.6%	Shares	Sole	2024-05-14
2023-12-31	$815,242	3,524	+77.5%	Shares	Sole	2024-02-15
2023-09-30	$436,594	1,985	+3.4%	Shares	Sole	2023-11-14
2023-06-30	$408,510	1,920	+6.7%	Shares	Sole	2024-05-14
2023-03-31	$402,191	1,800	+9.6%	Shares	Sole	2024-05-14
2022-12-31	$386,364	1,642	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.